INCOME TAX: (Tables)

12 Months Ended

Mar. 31, 2020

Income Tax Disclosure [Abstract]

Schedule of Total Income Tax Expense (Benefit)

Total income tax expense (benefit) was allocated as follows (dollars in thousands): 

	Year ended March 31,
	2020		2019		2018
Continuing operations	$	(40,276)	$	(45,409)	$	(65,723)
Discontinued operations	207		470,346		42,952
	$	(40,069)	$	424,937	$	(22,771)

Schedule of Components of Income Tax Expense (Benefit)

Income tax expense (benefit) attributable to loss from continuing operations consists of (dollars in thousands): 

	Year ended March 31,
	2020		2019		2018
Current:
U.S. Federal	$	(33,715)	$	(39,534)	$	(33,626)
Non-U.S.	146		323		115
State	171		(16,092)		(4,414)
	(33,398)		(55,303)		(37,925)
Deferred:
U.S. Federal	(5,103)		1,245		(26,884)
Non-U.S.	(1,006)		149		21
State	(769)		8,500		(935)
	(6,878)		9,894		(27,798)
Total	$	(40,276)	$	(45,409)	$	(65,723)

Schedule of Income before Income Tax, Domestic and Foreign

Loss before income tax attributable to U.S. and non-U.S. continuing operations consists of (dollars in thousands):

	Year ended March 31,
	2020		2019		2018
U.S.	$	(160,457)	$	(174,867)	$	(132,552)
Non-U.S.	(5,080)		(4,489)		(470)
Total	$	(165,537)	$	(179,356)	$	(133,022)

Schedule of Effective Income Tax Rate Reconciliation

Below is a reconciliation of expected income tax benefit computed by applying the U.S. federal statutory rate of 21.0% for fiscal 2020 and 2019 and the blended U.S. federal statutory rate of 31.5% for fiscal 2018 to loss before income taxes to actual income tax benefit from continuing operations (dollars in thousands): 

	Year ended March 31,
	2020		2019		2018
Computed expected income tax benefit	$	(34,763)	$	(37,665)	$	(41,967)
Increase (reduction) in income taxes resulting from:
State income taxes, net of federal benefit	(473)		(5,998)		(3,329)
Research and other tax credits	(1,517)		(3,141)		(1,229)
Effect of federal rate change on deferred taxes	—		—		(24,565)
Nondeductible expenses	838		426		431
Stock-based compensation	5,025		(5,350)		4,452
Non-U.S. subsidiaries taxed at other than 35%	230		1,343		332
Adjustment to valuation allowances	(2,245)		5,204		—
Net operating loss carryback taxed at other rates	(7,360)		—		—
Other, net	(11)		(228)		152
	$	(40,276)	$	(45,409)	$	(65,723)

Schedule of Deferred Tax Assets and Liabilities

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at March 31, 2020 and 2019 are presented below (dollars in thousands).  

	2020		2019
Deferred tax assets:
Accrued expenses	$	3,978	$	3,347
Deferred revenue	16		19
Lease liabilities	4,939		—
Net operating loss carryforwards	33,516		29,032
Stock-based compensation	8,076		10,770
Nonqualified deferred compensation	2,815		3,147
Other	4,018		3,102
Total deferred tax assets	57,358		49,417
Less valuation allowance	(32,971)		(34,356)
Net deferred tax assets	24,387		15,061
Deferred tax liabilities:
Prepaid expenses	(2,239)		(1,222)
Capitalized software costs	(244)		(636)
Property and equipment	(1,498)		(440)
Right-of-use assets	(4,147)		—
Intangible assets	(9,605)		(5,631)
Deferred commissions	(3,817)		(2,586)
Accrued expenses	(2,189)		(4,550)
Total deferred tax liabilities	(23,739)		(15,065)
Net deferred tax assets (liabilities)	$	648	$	(4)

Schedule of Unrecognized Tax Benefits Roll Forward

The following table sets forth changes in the total gross unrecognized tax benefits for the fiscal years ended March 31, 2020, 2019 and 2018 (dollars in thousands):

	Year ended March 31,
	2020		2019		2018
Balance at beginning of period	$	19,600	$	15,415	$	12,870
Increases related to prior year tax positions	2,458		325		1,134
Decreases related to prior year tax positions	(1,048)		(292)		(208)
Increases related to current year tax positions	2,433		5,483		3,172
Lapse of statute of limitations	(43)		(1,331)		(1,553)
Balance at end of period	$	23,400	$	19,600	$	15,415